IntegriChain Executive and Leadership Team

June, 2026

Leadership Overview

IntegriChain has 4 executives leading key functions including strategy, finance, technology, and operations.

Driven by innovation, IntegriChain provides the strategy, data, applications, and business process infrastructure for market access and therapy commercialization, empowering pharmaceutical manufacturers to optimize their market access and commercialization efforts.

Leadership Roles at IntegriChain

  • Co-Founder & Chief Executive Officer - Joshua Halpern
  • Chief Financial Officer - Matthew Heyman
  • Chief Operating Officer - Sean Downey
  • Chief Technology Officer - Bradley Burget
  • Joshua Halpern - Co-Founder & Chief Executive Officer

    Joshua Halpern, the Co-Founder & Chief Executive Officer at IntegriChain, directs the overarching strategy for therapy commercialization and market access. Halpern architects the business process infrastructure, ensuring seamless integration of data, applications, and consulting expertise. This leadership role focuses on empowering pharmaceutical innovators to digitalize market access operations, thereby freeing up resources for enhanced data-driven decision support. By guiding the company's vision, Joshua Halpern ensures IntegriChain remains at the forefront of specialty and precision medicine access solutions. The Chief Executive Officer's mandate includes fostering strategic partnerships and driving the company's growth trajectory within the competitive pharmaceutical landscape. This involves a deep understanding of payer contracting, patient services, and distribution channel dynamics, all critical components of successful therapy commercialization.

    Matthew Heyman - Chief Financial Officer

    Matthew Heyman, the Chief Financial Officer at IntegriChain, manages the financial strategy and operational fiscal health of the organization. Heyman oversees all financial planning, budgeting, and reporting activities, ensuring robust financial controls and compliance with industry regulations. This executive's responsibilities extend to optimizing financial performance and supporting strategic investments in technology and market expansion. By meticulously managing financial resources, Matthew Heyman enables IntegriChain to deliver its comprehensive data and business process platform for therapy commercialization. The Chief Financial Officer's role is crucial in maintaining investor confidence and securing the capital necessary for sustained growth and innovation in the pharmaceutical access sector. Heyman's expertise ensures the financial viability of the ICyte Platform and its associated services.
    Matthew Heyman

    Sean Downey - Chief Operating Officer

    Sean Downey, the Chief Operating Officer at IntegriChain, oversees the operational execution of the company's data and business process platform for therapy commercialization. Downey manages the day-to-day operations, ensuring the efficient delivery of services related to market access and therapy commercialization. This executive's purview includes optimizing the orchestration of commercial and government payer contracting, patient services, and distribution channels for pharmaceutical manufacturers. By streamlining operational workflows, Sean Downey enhances the effectiveness of the ICyte Platform, enabling clients to focus on strategic market access initiatives. The Chief Operating Officer's commitment to operational excellence ensures IntegriChain consistently meets the evolving needs of the pharmaceutical industry, driving efficiency and client success.

    Bradley Burget - Chief Technology Officer

    Bradley Burget, the Chief Technology Officer at IntegriChain, spearheads the technological vision and development of the ICyte Platform. Burget directs the engineering teams responsible for building and scaling the data and business process infrastructure that supports therapy commercialization. This leadership position involves ensuring the platform's security, reliability, and advanced analytical capabilities, crucial for managing complex financial, operational, and commercial data sets. By driving technological innovation, Bradley Burget empowers pharmaceutical manufacturers to digitalize their market access operations effectively. The Chief Technology Officer's focus is on leveraging cutting-edge technology to provide actionable insights and support data-driven decision-making in the era of specialty and precision medicine, ensuring IntegriChain's technological superiority.

    Explore Leadership Teams in Healthcare Software

    Frequently Asked Questions Regarding IntegriChain Top Executives and Leadership Team

    Who leads IntegriChain?
    IntegriChain is led by Joshua Halpern (Co-Founder & Chief Executive Officer), along with executives such as Matthew Heyman (Chief Financial Officer) and Sean Downey (Chief Operating Officer).
    Who is part of IntegriChain’s executive team?
    The executive team of IntegriChain includes leaders such as Joshua Halpern (Co-Founder & Chief Executive Officer), Matthew Heyman (Chief Financial Officer), Sean Downey (Chief Operating Officer) and other senior executives.
    How many executives does IntegriChain have?
    IntegriChain has 4 executives leading key business areas.
    What roles are included in IntegriChain’s leadership team?
    The leadership team of IntegriChain includes roles such as Co-Founder & Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, Chief Technology Officer.